Arena Pharmaceuticals Inc (NASDAQ:ARNA)

40.80
Delayed Data
As of Feb 16
 +0.03 / +0.07%
Today’s Change
11.30
Today|||52-Week Range
41.92
+20.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-19.4M-60.5M-108.0M-22.1M
 
 
 
 
 
Depreciation8.2M9.2M10.0M9.4M
 
 
 
 
 
Total Other Cash Flow-941.0K-40.2M15.1M33.5M
 
 
 
 
 
Funds From Operations-12.2M-91.5M-82.8M20.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-85.0M9.9M15.3M82.9M
 
 
 
 
 
Net Cash Flow - Operating Activities72.8M-101.4M-98.1M-62.1M
 
 
 
 
 
 
InvestingCapital Expenditures-9.2M-8.9M-11.0M-950.0K
 
 
 
 
 
Fixed Asset Disposal60.0K47.0K2.2M954.0K
 
 
 
 
 
Other Investing - Sources439.0K49.8M609.0K--
 
 
 
 
Net Cash Flow Investing-8.7M40.9M-8.2M-750.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction-1.7M-2.1M-2.5M-3.0M
 
 
 
 
 
Net Proceeds Stock Sale3.3M5.2M103.6M370.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00320.0K
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing1.7M3.2M101.1M-2.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0K-1.3M-1.9M-294.0K
 
 
 
 
 
 
Net Change In Cash65.8M-57.3M-5.1M-65.2M